Morbidity and mortality after stroke--eposartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES).
Weinberger
Jesse
J
Neurology Department, Mount Sinai School of Medicine, New York, NY 10029, USA. Jesse.Weinberger@mssm.edu